Corcept Therapeutics Incorporated (NASDAQ:CORT) notched a 0.19% intraday gain moving at $20.85. When the opening bell rang, the price was $20.67. The number of shares that were traded during the day was 1.86 million, which corresponds to its 3-month volume average of 1.74 million shares a day.Corcept Therapeutics Incorporated (CORT) Analyst Opinion
Corcept Therapeutics Incorporated has a consensus outperform rating from 4 Wall Street analysts, and the number of shares currently sold short amount to at least 8.99% of shares outstanding. The stock spiked 22.43% last month and is up 15.45 this year. Wall Street is only getting more bullish on the stock, with 3 of analysts who cover CORT having a buy-equivalent rating. Analysts have placed a $20.75 price target on Corcept Therapeutics Incorporated, suggesting a -0.48% decline from recent close. It’s currently trading about -0.43% below its 52-week high.
Corcept Therapeutics Incorporated (CORT) revenue totaled $42.46 million up 19.4% from the previous quarter.Corcept Therapeutics Incorporated (NASDAQ:CORT) Intraday View
This stock (CORT) is ahead of its 52-week low with 211.19%. Its last month’s stock price volatility remained 4.91% which for the week stands at 5.16%. The share price has moved forward from its 20 days moving average, trading at a distance of 16.43% and stays 16.71% away from its 50 days moving average. Over the last five days, shares have managed 10.73% gains and now is up 41.66% since hitting its 200-day moving average of $16.48. Corcept Therapeutics Incorporated (CORT) has made its way to a 12-month gain of 156.77%.
Turning to Palatin Technologies, Inc. (NYSE:PTN), its shares were trading at $0.87 a retreat of $-0.03, on the trading floor. The stock, after opening at $0.88, touched a high of $0.9 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.5. Palatin Technologies, Inc. has 1 buy ratings, 0 holds and 0 sells even after the stock tumbled -16.71% from its high of $1.05 to a $163.97 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 1.5 to 1.5 during a month. Analysts set a 12-month price target of $6 a share. The target implies a 589.66% spike from where the shares are currently trading. Also, the current price highlights a discount of 589.66% to analysts’ high consensus price target.Palatin Technologies, Inc. (NYSE:PTN) Intraday Trading
The counter witnessed a trading volume of 1.34 million shares versus an average volume of 1.61 million shares during last trading session. Its last month’s stock price volatility remained 5.51% which for the week approaches 4.9%. The lowest price the stock reached in the last trading day was $0.86 and compares with the $0.29 52-week low. The stock recovered 206.73% since its low point and has performed 1.82% year-to-date.